Wang, Jianyi
Ye, Qing
Xu, Jing
Benedek, Gil
Zhang, Haiyue
Yang, Yuanyuan
Liu, Huan
Meza-Romero, Roberto
Vandenbark, Arthur A.
Offner, Halina
Gao, Yanqin
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS075887, R01NS076013)
The Department of Veterans Affairs, Veterans Health Administration,
Article History
Received: 13 September 2016
Revised: 21 November 2016
Accepted: 6 December 2016
First Online: 17 December 2016
Compliance with Ethical Standards
:
: This work was supported by the NIH/National Institute of Neurological Disorders and Stroke (NINDS) grants R01NS075887 (HO) and R01NS076013 (HO) and by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. The contents do not represent the views of the Department of Veterans Affairs or the United States Government.
: Dr. Offner, Dr. Benedek, Dr. Meza-Romero, and Dr. Vandenbark and OHSU have a significant financial interest in Artielle ImmunoTherapeutics, Inc., a company that may have a commercial interest in the results of this research and technology. This potential conflict of interest has been reviewed and managed by the OHSU and VAMC Conflict of Interest in Research Committees. No other authors have a conflict of interest.
: This article does not contain any studies with human participants.